WO1990011370A1 - Sonde de polynucleotide, procede et kit d'identification et de detection de bacteries gram-negatives - Google Patents
Sonde de polynucleotide, procede et kit d'identification et de detection de bacteries gram-negatives Download PDFInfo
- Publication number
- WO1990011370A1 WO1990011370A1 PCT/NL1990/000033 NL9000033W WO9011370A1 WO 1990011370 A1 WO1990011370 A1 WO 1990011370A1 NL 9000033 W NL9000033 W NL 9000033W WO 9011370 A1 WO9011370 A1 WO 9011370A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probe
- gram
- species
- bacteria
- probes
- Prior art date
Links
- 239000000523 sample Substances 0.000 title claims abstract description 87
- 241000894006 Bacteria Species 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 36
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 26
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 26
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 25
- 238000001514 detection method Methods 0.000 title claims description 13
- 241000894007 species Species 0.000 claims abstract description 24
- 239000012634 fragment Substances 0.000 claims abstract description 23
- 101710116435 Outer membrane protein Proteins 0.000 claims abstract description 17
- 241000588921 Enterobacteriaceae Species 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 11
- 238000003752 polymerase chain reaction Methods 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 108020004999 messenger RNA Proteins 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 abstract description 3
- 238000011109 contamination Methods 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 239000013060 biological fluid Substances 0.000 abstract 1
- 238000011835 investigation Methods 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 description 16
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 14
- 238000009396 hybridization Methods 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 11
- 101150058164 phoE gene Proteins 0.000 description 11
- 241000607768 Shigella Species 0.000 description 10
- 241000607142 Salmonella Species 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241001148137 Salmonella enterica subsp. enterica serovar Panama Species 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 239000003298 DNA probe Substances 0.000 description 6
- 241000588914 Enterobacter Species 0.000 description 6
- 241000588748 Klebsiella Species 0.000 description 6
- 238000000211 autoradiogram Methods 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 241001646716 Escherichia coli K-12 Species 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 239000013611 chromosomal DNA Substances 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 241000588919 Citrobacter freundii Species 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 241000607471 Edwardsiella tarda Species 0.000 description 3
- 241000588697 Enterobacter cloacae Species 0.000 description 3
- 241000588915 Klebsiella aerogenes Species 0.000 description 3
- 108010079246 OMPA outer membrane proteins Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 241000588770 Proteus mirabilis Species 0.000 description 3
- 241000588778 Providencia stuartii Species 0.000 description 3
- 241001355103 Salmonella enterica subsp. enterica serovar Braenderup Species 0.000 description 3
- 241001135268 Salmonella enterica subsp. enterica serovar Derby Species 0.000 description 3
- 241000607715 Serratia marcescens Species 0.000 description 3
- 241000607762 Shigella flexneri Species 0.000 description 3
- 241000607760 Shigella sonnei Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 2
- 208000031729 Bacteremia Diseases 0.000 description 2
- 108020000946 Bacterial DNA Proteins 0.000 description 2
- 241000305071 Enterobacterales Species 0.000 description 2
- 241001522878 Escherichia coli B Species 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000607758 Shigella sp. Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000607734 Yersinia <bacteria> Species 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 101150042295 arfA gene Proteins 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 101150087557 omcB gene Proteins 0.000 description 2
- 101150115693 ompA gene Proteins 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 229940115939 shigella sonnei Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 238000007900 DNA-DNA hybridization Methods 0.000 description 1
- 241000607473 Edwardsiella <enterobacteria> Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241000644323 Escherichia coli C Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 101100297420 Homarus americanus phc-1 gene Proteins 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108700028353 OmpC Proteins 0.000 description 1
- 108700006385 OmpF Proteins 0.000 description 1
- 101710203389 Outer membrane porin F Proteins 0.000 description 1
- 101710160104 Outer membrane protein F Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000110797 Polygonum persicaria Species 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588768 Providencia Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 108020004518 RNA Probes Proteins 0.000 description 1
- 239000003391 RNA probe Substances 0.000 description 1
- 241000405383 Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607766 Shigella boydii Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 201000010666 keratoconjunctivitis Diseases 0.000 description 1
- 230000010436 membrane biogenesis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 101150110245 ompC gene Proteins 0.000 description 1
- 101150073640 ompF gene Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the invention relates to a polynucleotide probe which speci ⁇ fically recognizes a genus or species of Gram-negative bacteria.
- a rapid determination of microorganisms is of great impor- tance in medicine and health care also, for example for localizing and combating infections. Furthermore, there is also a need for rapid and effective methods of determination for the presence of bacteria in the environmental sector.
- the microorganism is subjected to a large series of tests in each of which it is determined whether or not a specific enzyme activity occurs. The combination of activities found gives an indication for the species of bacteria or for the genus of bacteria in question. Methods of this type are laborious and, above all, not definitive: a bacterium or group of bacteria is detected only with a specific probability (of less than 100%).
- DNA-DNA hybri ⁇ dization is regarded as a highly promising technique (see Klausner and Wilson, Bio-Technology 1_, 471-478, 1983).
- a DNA fragment which is specific for a species of bac ⁇ teria or a group of bacteria is sought as a "probe" for structural ⁇ ly related DNA in bacteria which it is desired to identify.
- the great advantage of a detection technique of this type is that testing is for the genotype instead of, as customary, for the phenotype.
- the route which has been followed up to now for developing DNA probes for bacteria is the fragmentation of bacterial DNA in a relatively arbitrary manner, cloning fragments in plasmid vectors and investigating, with the aid of radioactive markers, whether fragments hybridize specifically with bacterial DNA.
- the sequence of such frag- ent ⁇ must then be determined, after which oligonucleotides are prepared and tested again.
- the disadvantage of probes of this type is that they demand a prolonged and laborious preparation, a prepa ⁇ ration which, moreover, must be developed entirely anew for a subsequent species of bacteria to be investigated, as a result of which the composition of a kit for determining various bacteria in samples on the basis of such probes is virtually impossible.
- Probes based on ribosomal RNA are also known: however, in a number of cases these display a troublesome cross-reactivity (inadequate inclusivity and exclusivity). It has been found that certain sequences of genes which code for outer membrane proteins of Gram-negative bacteria and the sequences complementary hereto are very suitable as a poly ⁇ nucleotide probe with which microorganisms of a specific species or genus can be detected, for example in foodstuffs, in a clinical specimen or in the environment.
- the polynucleotide probe according to the invention therefore contains a polynucleotide which corresponds with or is complementa ⁇ ry to a fragment of a gene or messenger RNA coding for an outer membrane protein of a Gram-negative bacterium.
- An advantage of the polynucleotide probe according to the invention is that this contains only a relatively small number of nucleotides (of the order of 10-40 base pairs), as a result of which this can be simply prepared and used. At the same time, this probe proves to be specific for a certain genus or species of Gram- negative bacteria.
- the polynucleotide probe can contain either a polydeoxyribo- nucleotide (DNA probe) or a polyribonucleotide (RNA probe).
- DNA probe polydeoxyribo- nucleotide
- RNA probe polyribonucleotide
- polynucleotide does not indicate a specific minimum number of nucleic acids per molecule and this term is therefore not in absolute contrast to "oligonucleotide”.
- a further advantage of the polynucleotide probe according to the invention is that the hybridization can also be made detectable by other methods, for example by the so-called PCR (polymerase chain reaction) method. Furthermore, the probes are relatively easy to combine into a kit with which a series of relevant Gram-negative bacteria can be identified, for example in foodstuffs, body fluid, water samples and the like.
- Outer membrane proteins are proteins which are present in the outer membrane of the cell envelope of Gram-negative bacteria, where they fulfil various functions such as allowing the passage of nutrients (the pore-forming outer membrane proteins or porines) and of larger dissolved substances and contributing to the structure and the binding of the outer membrane. These proteins are desig ⁇ nated OmpA, OmpC, OmpF, PhoE, LamB, Tsx, OmpT, FhuA, BtuB, FepA, FecA, etc.
- the heterologous fragments of the outer membrane proteins frequently occur in the parts of the outer membrane proteins which are exposed at the cell surface, while the membrane-bridging parts are substantially preserved. Therefore, the fragments of the genes which correspond to the exposed fragments of the outer membrane proteins are particularly suitable as a basis for specific poly ⁇ nucleotide probes according to the invention.
- An example of a suitable probe for detecting Salmonella species is a probe which contains the 23-mer oligodeoxynucleotide TTTAGTAGACGGGCCGCCAGGGA, corresponding to an exposed part of the OmpA protein of S. typhimurium.
- the probes according to the invention can be built up on the basis of the outer membrane proteins, in principle of all Gram- negative bacteria, and therefore are used for detecting the same Gram-negative species or genera of bacteria.
- Probes for Enterobac ⁇ teriaceae are particularly important because these bacteria play a major role in infections, food poisoning, biological contamination and the like. Bacteria of the genera Enterobacter, Klebsiella, Salmonella, Yersinia, Edwardsiella, Erwinia, Serratia, Citrobacter, Proteus and Providencia may be mentioned.
- the invention can also be used for detecting Gram-negative bacteria other than Enterobac ⁇ teriaceae, such as Pseudomonas.
- the polynucleotide probes according to the invention recog ⁇ nize specific genera of bacteria and possibly species of bacteria.
- a probe derived from an outer membrane protein of Salmonella typhimurium proves to recognize all Salmonella species and not to show any false-positive reaction with other species.
- the current categorization of bacteria in genera and species is by no means perfect, as a result of which it can arise that a probe derived from a species or strain belonging to a specific genus does not recognize a species with the same genus name.
- a probe derived, for example, from an Escherichia coli also recognizes Shigella sp., which confirms that E. coli and Shigella sp. belong to the same genus and perhaps even to a single species (see W.J. Brenner in Bergey's Manual of Systematic Bacte ⁇ riology, vol. I, pp. 410-411, Williams & Williams Co. Baltimore (1984)).
- the fact that the polynucleotide probes according to the invention have such a high exclusivity and inclusivity is particu ⁇ larly surprising in view of the results with DNA probes according to the prior art.
- the polynucleotide probe according to the invention can be prepared on the basis of a suitable fragment of a gene or messenger RNA coding for an outer membrane protein of the chosen bacterium by lining up together the relevant nucleotides according to a proce ⁇ dure known per se.
- the preparation can advantageously be automated using a DNA synthesis installation.
- the ability of the probe thus obtained selectively to detect bacteria is demonstrated, for example, by means of hybridization in a so-called slot-blot procedure (P.J. Carter et al., Cell 38, 835- 840 (1984)).
- the DNA of the bacterium or bacteria to be investigated is liberated from the cells and attached to a filter and then brought into contact with a probe according to the invention, provided with, for example, a radioactive label. After hybridization it is investigated, for example by means of an auto- radiogram, whether the sample has reacted with a nucleotide sequence, in other words has recognized this nucleotide sequence.
- PCR polymerase chain reaction
- Another recently developed procedure which can be used to detect hybridization is the coupling to viral RNA, after which the probe is hybridized with the DNA sample to be determined. Any hybridization can then be demonstrated by in vitro reproduction of the hybridized RNA with the aid of viral replicas. In this way such a large amount of the hybridized RNA can be obtained in a short time that detection without radioactive labelling is pos- sible. See also P.M. Lizardi et al., Biotechnology ⁇ _, 1197-1102 (1988).
- the polynucleotide probe can be used selectively to detect a species or genus of bacteria within a multiplicity of bacteria, for example in foodstuffs.
- the polynucleotide probe according to the invention is also very suitable for identifying isolated bacteria, where appropriate in a pure culture, for medical use (infections).
- the invention therefore also relates to a method for the detection and identification of Gram-negative bacteria, in parti ⁇ cular of Enterobacteriaceae, using the polynucleotide probe- as described above.
- the method consists, for example, in isolating the poly ⁇ nucleotide material from the sample to be investigated, or attaching it to a carrier, in a known manner and then bringing it into contact with a probe according to the invention.
- the hybri- dization can then be detected by various methods, for example by using 32 P-ATP, viral replicas etc.
- the method according to the invention is particularly advantageous when using the PCR method as indicated above, in which case the polynucleotide fragment repro ⁇ quizd can be detected in various ways.
- the invention also relates to a kit for the selective detection/identification of Gram-negative bacteria, which kit contains one or more of the polynucleotide probes described above.
- this kit contains a combination of DNA probes for testing for the presence of a series of Enterobacteriaceae.
- the kit according to the invention can also contain means for isolating the (hybridized) polynucleotide, such as filters, for detecting the hybridization signal, such as labelling substances, and for in vitro reproduction of hybridized polynucleotide fragments, such as a DNA-polymerase or a viral polymerase, and also other means for carrying out an iden ⁇ tification of bacteria, and if desired a method for this.
- the examples below illustrate that polynucleotide sequences which code for parts of outer membrane proteins exposed at the cell surface, or the sequences complementary to these, can be used as genus-specific probes for the identification of Gram-negative bacteria.
- the oligodeoxynucleotides are prepared automatically with the aid of a Biosearch 8600 DNA synthesizer and are then purified by means of high pressure liquid chromatography.
- the oligomers are labelled at the 5'-end by enzymatically catalyzed transfer of 32 P phosphate from [ ⁇ - 3*** P]ATP (3000 Ci/mmol, Amersham Int. pic, Amersham, England) with T4 polynucleotide kinase (Pharmacia, Uppsala, Sweden) using the method of Maniatis et al., Molecular Cloning, a laboratory manual, Cold Spring Harbor, N.Y. (1982). Bacterial strains and plasmids
- E. coli B and C Institute for Molecular Biology and Medical Biotechnology, University of Utrecht).
- coli strain S1, S2, S3, S4, S5, S6, S8 and S9 isolated from blood cultures of patients having bacteremia, F1, F5, F6, F9 and F12 isolated from faeces of healthy volunteers, and U6, U7, U8, U11 and U13 isolated from virine of patients having urinary tract infections, are described by Overbeeke and Lugtenberg (J. Gen. Microbiol. ⁇ 21373-380 (1980).
- Strain EIEC an entero- invasive E.
- enterobacterial strains used were Edwardsiella tarda, Enterobacter aerogenes, Citrobacter freundii, Klebsiella pneumoniae, Proteus mirabilis, Providencia stuartii, Salmonella braenderup, Salmonella derby, Salmonella panama, Serratia marcescens, Shigella flexneri, Shigella sonnei (H. Hofstra, J. Dankert, J. Gen. Microbiol. 119, 123-131 (1980), Salmonella typhimurium 8J2353 (T. Sato, T. Yura, J. Bacteriol.
- Salmonella typhimurium LT a Salmonella typhimurium B7121-2 pro
- Salmonella typhimurium KB1711 K. Bauer et al., J. Bacterol. .161.: 813-816 (1985)
- the following were used for the polymerase chain reaction procedure: E. coli K-12 strain CGSC4234 (E. coli Genetic Stock Center, Department of Human Genetics, Yale University School of Medicine, New Haven, Conn.), Salmonella panama and Salmonella typhimurium SJ2353.
- pACYC184 A. Chang, S. Cohen, J. Bacteriol. J_34: 1141-1156. (1978)
- pJP29 contains the phoE gene of E. coli, D. Bosch et al., J. Mol. Biol. 189, 449-455 (1986)
- pKP 2 contains the phoE gene of Klebsiella pneumoniae, P. van der Ley et al., Eur. J. Biochem. 164: 469-475 (1987)
- pEC17 contains the phoE gene of Enterobacter cloacae, C.
- Verhoef et al. Gene 32: 107-115 (1984), plasmid pBR322 (F. fiolivar et al., Gene 2 : 95-113 (1977)) and its derivative pSTl (contains a portion of the phoE gene of Salmonella typhimurium, G. Spierings, not published).
- NC nitrocellulose
- the filters were pre-hybridized for 45 minutes at 60°C in 0.25% Protifar (Nutricia NV, Zoetermeer), 6 x SSC (90 mM sodium chloride, 90 mM sodium citrate pH 7.0). After adding the probe (10 pmol DNA), the filter was hybridized for 1.5 hours at 60 ⁇ C. The filters were washed twice with 6 x SSC at 60°C and autoradiograms of the filters were made by exposure to a Fuji X-ray film for 3 days. DNA spot procedure: 1 ⁇ l of the plasmid solutions ( « 0.5 ⁇ g/ ⁇ l) was spotted on NC. The filters were then treated and hybridized as described in the slot-blot hybridization procedure.
- ST1/ST3c and ST2/ST3c were used as primer couples, resulting in the reproduction of fragments of, respectively, 285 and 156 base pairs.
- 40 cycles of 1 minute at 92 ⁇ C, 2 minutes at 42 ⁇ C and 2 minutes at ⁇ '-'C were run with the aid of a programmable incubator block (PHC-1, New Brunswick Scientific B.V., Soest, Holland). 10 ⁇ l of the reaction mixture was analysed on a 1.3% agarose gel.
- Salmonella probes Three Salmonella probes were synthesized, based on the first, the second and the third fragment of the OmpA protein of S. typhimurium exposed at the cell surface. The DNA sequences of these fragments are indicated as ST1 , ST2 and ST3c respectively in Figure 1. The inclusivity and exclusivity of ST3c was tested in a slot-blot hybridization procedure. Figure 4 shows the autoradiogram of the filter after hybridization with the probe. The following strains were applied to the filter: 1A, P. mirabilis; 1B, S. panama; 1C, S. typhimurium; 2A, S. marcescens; 2B, C. freundii, 2C, K. pneumoniae; 3A, E.
- the probe does not react with the other Enterobacte ⁇ riaceae. However, under the test conditions used the probe does not react with S. panama. Under the conditions used in the PCR reaction ( Figure 5), however, both the chromosomal DNA isolated from S. panama (Slots 5 and 6) and the chromosomal DNA isolated from S. typhimurium (Slots 3 and 4) were found to be used as substrate. When the chromosomal DNA isolated from E. coli was offered as substrate, amplification of the fragment of 285 base pairs (Slot 1) also took place when the probes ST. and ST3c were used, and also of the fragment of 156 base pairs (Slot 2) when the probes ST2 and ST3c were used.
- Example II Shigella probe For the development of the Shigella probe, use was made of the very close relationship which exists between Shigella and E. coli (see W.J. Brenner, Family I Enterobacteriaceae in: Bergey's Manual of Systematic Bacteriology, vol. I, The Williams & Wilkins Co., Baltimore, pp. 410-411 (1984)). It was therefore assumed that the sequences of the phoE genes of Shigella species are virtually identical to the known sequence of E. coli K-12 phoE gene. The Shigella probe for which the sequence is shown in Figure 2 together with the corresponding sequences of K. pneumoniae and E. cloacae (P.
- van der Ley et al. is based on the fifth portion of the PhoE protein of E. coli exposed at the cell surface.
- the specificity of the probe was tested with the aid of a slot-blot hybridization procedure.
- the autoradiogram is shown in Fig. 6.
- the following strains were applied to the filter: 1A, P. mirabilis; 1B, S. panama; 1C, S ⁇ typhimurium; 2A, S. marcescens; 2B, C. freundii; 2C, K. pneumoniae; 3A, E. tarda; 3B, E. aerogenes; 3C, P.
- the probe was tested on a number of E. coli strains isolated from blood cultures of patients having bacte- remia, from faeces of healthy volunteers and from urine of patients having urinary tract infections. These strains represent a variety of 0 and K serotypes (as described by Overbeeke and Lugtenberg, J.
- Figure 7 shows that the probe reacted with all these different strains.
- the Enterobacter probe and the Klebsiella probe are based on the eighth fragment of the PhoE protein of, respectively, E. cloacae and K. pneumoniae exposed at the cell surface.
- the specificity of the probes was investigated in DNA spot tests.
- the autoradiogram of the filter hybridized with the Enterobacter probe and hybridized with the Klebsiella probe is shown in Figure 8 on the left-hand photograph and right-hand photograph respectively.
- the following plasmids were applied to the filters: 1A, pEC17; 1B, pBR322; pJP29; 2B, pACYC184;
- Klebsiella probe reacts only with pKP 2 .
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne une sonde de polynucléotides (ADN ou ARN) reconnaissant un gène ou une espèce de bactérie gram-négatives, notamment d'un gène ou d'une espèce d'Enterobacteriaceae. Ladite sonde correspond à un fragment relativement court d'une protéine de membrane extérieure de la bactérie et est hautement spécifique (exclusive et inclusive) au gène ou à l'espèce étudiés. La sonde destinée à différents genres ou à différentes espèces est utilisée dans un procédé de contrôle de contamination bactérienne, par exemple dans des produits alimentaires ou dans des fluides biologiques, et peut se présenter sous la forme d'un kit de diagnostic.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8900670A NL8900670A (nl) | 1989-03-17 | 1989-03-17 | Polynucleotide-probe, werkwijze en kit voor het identificeren en opsporen van gram-negatieve bacterien. |
NL8900670 | 1989-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1990011370A1 true WO1990011370A1 (fr) | 1990-10-04 |
Family
ID=19854316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL1990/000033 WO1990011370A1 (fr) | 1989-03-17 | 1990-03-16 | Sonde de polynucleotide, procede et kit d'identification et de detection de bacteries gram-negatives |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0464123A1 (fr) |
JP (1) | JPH05504672A (fr) |
AU (1) | AU5351790A (fr) |
NL (1) | NL8900670A (fr) |
WO (1) | WO1990011370A1 (fr) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0479117A1 (fr) * | 1990-10-05 | 1992-04-08 | F. Hoffmann-La Roche Ag | Méthodes et réactifs pour l'identification bactérienne |
EP0669989A4 (fr) * | 1991-08-22 | 1994-12-20 | Univ Washington | Sondes de polynucleotide de detection de salmonelle. |
LT3828B (en) | 1993-11-10 | 1996-03-25 | Fermentas Biotech Inst | Process for detecting salmonella bacteries and probe for the same |
US5620847A (en) * | 1990-10-05 | 1997-04-15 | Hoffman-La Roche Inc. | Methods and reagents for detection of bacteria in cerebrospinal fluid |
US5635348A (en) * | 1990-10-05 | 1997-06-03 | Hoffmann-La Roche Inc. | Method and probes for identifying bacteria found in blood |
US5656740A (en) * | 1994-06-06 | 1997-08-12 | E. I. Du Pont De Nemours And Company | Nucleic acid fragments useful in the detection of Salmonella |
US5747257A (en) * | 1996-02-29 | 1998-05-05 | E. I. Du Pont De Nemours And Company | Genetic markers and methods for the detection of escherichia coli serotype-0157:H7 |
WO1998018958A1 (fr) * | 1996-10-28 | 1998-05-07 | Compagnie Gervais Danone | Procede de mise en evidence de contaminants microbiologiques vivants dans un echantillon de produit a usage alimentaire |
US5922538A (en) * | 1996-11-08 | 1999-07-13 | E.I. Du Pont De Nemours And Company | Genetic markers and methods for the detection of Listeria monocytogenes and Listeria spp |
EP0652291A4 (fr) * | 1992-07-07 | 1999-08-18 | Fuso Pharmaceutical Ind | Sonde pour diagnostiquer des maladies infectieuses. |
US6790661B1 (en) | 1999-07-16 | 2004-09-14 | Verax Biomedical, Inc. | System for detecting bacteria in blood, blood products, and fluids of tissues |
WO2005090596A3 (fr) * | 2004-03-19 | 2005-11-24 | Univ Catholique Louvain | Dosage pour la detection et l'identification de micro-organismes |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0297291A2 (fr) * | 1987-06-03 | 1989-01-04 | BEHRINGWERKE Aktiengesellschaft | Protéine de la membrane extérieure F de Pseudomonas aeruginosa |
-
1989
- 1989-03-17 NL NL8900670A patent/NL8900670A/nl not_active Application Discontinuation
-
1990
- 1990-03-16 AU AU53517/90A patent/AU5351790A/en not_active Abandoned
- 1990-03-16 EP EP90905696A patent/EP0464123A1/fr not_active Withdrawn
- 1990-03-16 WO PCT/NL1990/000033 patent/WO1990011370A1/fr not_active Application Discontinuation
- 1990-03-16 JP JP2505368A patent/JPH05504672A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0297291A2 (fr) * | 1987-06-03 | 1989-01-04 | BEHRINGWERKE Aktiengesellschaft | Protéine de la membrane extérieure F de Pseudomonas aeruginosa |
Non-Patent Citations (3)
Title |
---|
Applied and Environmental Microbiology, Volume 55, No. 12, December 1989, American Society for Microbiology, (Washington, D.C., US), G. SPIERINGS et al.: "Development of Enterobacterium-Specific Oligonucleotide Probes based on the Surface-Exposed Regions of outer Membrane Proteins", pages 3250-3252 * |
Journal of Bacteriology, Volume 149, January 1982, (Washington, D.C., US), S.T. COLE et al.: "Cloning and Expression in Escherichia Coli K-12 of the Genes for Major outer Membrane Protein ompA from Shigella Dysenteriae, Enterobacter Aerogenes, and Serratia Marcescens", pages 145-150 * |
Journal of Clinical Microbiology, Volume 18, No. 1, July 1983, American Society for Microbiology, (Washington, D.C., US), A.M. PALVA: "OmpA Gene in Detection of Escherichia Coli and other Enterobacteriaceae by Nucleic Acid Sandwich Hybridization", pages 92-100 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635348A (en) * | 1990-10-05 | 1997-06-03 | Hoffmann-La Roche Inc. | Method and probes for identifying bacteria found in blood |
EP0479117A1 (fr) * | 1990-10-05 | 1992-04-08 | F. Hoffmann-La Roche Ag | Méthodes et réactifs pour l'identification bactérienne |
US5620847A (en) * | 1990-10-05 | 1997-04-15 | Hoffman-La Roche Inc. | Methods and reagents for detection of bacteria in cerebrospinal fluid |
EP0669989A4 (fr) * | 1991-08-22 | 1994-12-20 | Univ Washington | Sondes de polynucleotide de detection de salmonelle. |
EP1160334A3 (fr) * | 1992-07-07 | 2004-01-02 | Fuso Pharmaceutical Industries Ltd. | Sonde pour diagnostiquer des maladies infectieuses liées à pseudomonas aeruginosa |
EP0652291A4 (fr) * | 1992-07-07 | 1999-08-18 | Fuso Pharmaceutical Ind | Sonde pour diagnostiquer des maladies infectieuses. |
EP1167544A3 (fr) * | 1992-07-07 | 2004-03-03 | Fuso Pharmaceutical Industries Ltd. | Sonde pour diagnostiquer des maladies infectieuses à cause d' Escherichia coli, Klebsiella pneumoniae ou Enterobacter cloacae |
LT3828B (en) | 1993-11-10 | 1996-03-25 | Fermentas Biotech Inst | Process for detecting salmonella bacteries and probe for the same |
US5656740A (en) * | 1994-06-06 | 1997-08-12 | E. I. Du Pont De Nemours And Company | Nucleic acid fragments useful in the detection of Salmonella |
US5660981A (en) * | 1994-06-06 | 1997-08-26 | E. I. Du Pont De Nemours And Company | Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella |
US5747257A (en) * | 1996-02-29 | 1998-05-05 | E. I. Du Pont De Nemours And Company | Genetic markers and methods for the detection of escherichia coli serotype-0157:H7 |
WO1998018958A1 (fr) * | 1996-10-28 | 1998-05-07 | Compagnie Gervais Danone | Procede de mise en evidence de contaminants microbiologiques vivants dans un echantillon de produit a usage alimentaire |
US6472149B1 (en) | 1996-10-28 | 2002-10-29 | Compagnie Gervais Danone | Method for detecting live microbiological contaminants in a food product sample |
US5922538A (en) * | 1996-11-08 | 1999-07-13 | E.I. Du Pont De Nemours And Company | Genetic markers and methods for the detection of Listeria monocytogenes and Listeria spp |
US6790661B1 (en) | 1999-07-16 | 2004-09-14 | Verax Biomedical, Inc. | System for detecting bacteria in blood, blood products, and fluids of tissues |
WO2005090596A3 (fr) * | 2004-03-19 | 2005-11-24 | Univ Catholique Louvain | Dosage pour la detection et l'identification de micro-organismes |
US7785780B2 (en) | 2004-03-19 | 2010-08-31 | Universite Catholique De Louvain | Assay for detecting and identifying micro-organisms |
Also Published As
Publication number | Publication date |
---|---|
NL8900670A (nl) | 1990-10-16 |
EP0464123A1 (fr) | 1992-01-08 |
JPH05504672A (ja) | 1993-07-22 |
AU5351790A (en) | 1990-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5702895A (en) | Method and kit for detecting methicillin-resistant Staphylococcus aureus | |
JP2607496B2 (ja) | カンピロバクター検出用プローブ | |
JP2008154581A (ja) | 細菌ゲノム増幅反応用プライマー | |
Grimont et al. | DNA probe specific for Legionella pneumophila | |
HU196242B (en) | Process and reagent combination for identifying microorganisms by sandwich-hybridization of nucleic acids | |
US6004747A (en) | Salmonella identification by the polymerase chain reaction | |
WO1990011370A1 (fr) | Sonde de polynucleotide, procede et kit d'identification et de detection de bacteries gram-negatives | |
EP0353985A2 (fr) | Sonde d'acide nucléique pour la détection de Neisseria gonorrhoea | |
US5652102A (en) | Assay for enterohemorrhagic Escherichia coli 0157:H7 by the polymerase chain reaction | |
US5824795A (en) | Oligonucleotides for the detection of salmonella | |
Trotha et al. | Rapid ribosequencing–an effective diagnostic tool for detecting microbial infection | |
US5786147A (en) | Detection of enterobacteria | |
Olsen et al. | Isolation of a Salmonella‐specific DNA hybridization probe | |
EP1852512B1 (fr) | Méthode pour la détection et l'énumération de microorganismes | |
US5869642A (en) | Detection of the genus pectinatus | |
US20060177824A1 (en) | Salmonella detection identification | |
JPH02154700A (ja) | カンピロバクター属の異なる細菌種を特異的に検出するために有用な核酸プローブ | |
JP2001512665A (ja) | 大腸菌種に特異的なオリゴヌクレオチド並びにその種の細菌の検出および視覚化法 | |
US20060105369A1 (en) | Methods and kits for identifying Enterohaemorrhagic Escherichia coli O157:H7 strain | |
JP5094181B2 (ja) | プローブセット、プローブ固定担体及び検査方法 | |
JP2004290171A (ja) | 微生物の分子生物学的同定技術 | |
JP5089223B2 (ja) | プローブセット、プローブ固定担体及び検査方法 | |
JP5089222B2 (ja) | プローブセット、プローブ固定担体及び検査方法 | |
JP2025043943A (ja) | 細菌からの核酸抽出法 | |
JP5089220B2 (ja) | プローブセット、プローブ固定担体及び検査方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI JP KR NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1990905696 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1990905696 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1990905696 Country of ref document: EP |